Valuation: Anthem Biosciences Limited

Market Cap 529B 5.62B 5.08B 4.69B 4.25B 8.02B 8.26B 56.33B 22.39B 283B 21.1B 20.65B 899B P/E 2027 *
72.7x
P/E 2028 * 62.7x
Enterprise Value 519B 5.52B 4.99B 4.61B 4.17B 7.87B 8.11B 55.32B 21.99B 278B 20.72B 20.28B 883B EV / Sales 2027 *
20.3x
EV / Sales 2028 * 17.2x
Free-Float
19.11%
Yield 2027 *
0.21%
Yield 2028 * 0.21%
1 day-1.99%
1 week+5.65%
Current month+13.23%
1 month+8.83%
3 months+5.25%
6 months+19.67%
Current year+44.04%
1 week 899.1
Extreme 899.1
989.1
1 month 783.35
Extreme 783.35
989.1
Current year 579.15
Extreme 579.15
989.1
1 year 579.15
Extreme 579.15
989.1
3 years 579.15
Extreme 579.15
989.1
5 years 579.15
Extreme 579.15
989.1
10 years 579.15
Extreme 579.15
989.1
Manager TitleAgeSince
Chief Operating Officer 60 2006-09-26
Chief Tech/Sci/R&D Officer 60 2006-08-03
Chief Executive Officer 66 2006-06-12
Director TitleAgeSince
Chairman 66 2020-12-31
Director/Board Member 60 2006-08-03
Director/Board Member 60 2006-09-26
Change 5-day change 1-year change 3-year change Capi.($)
-1.99%+5.65%+37.89% - 5.75B
+0.76%+6.27%+42.49%+136.69% 1,280B
+1.73%+4.92%+46.99%+93.54% 675B
+0.58%+3.04%+27.34%+114.22% 521B
+1.14%+3.78%+39.98%+70.26% 386B
+1.29%+1.32%+62.80%+45.30% 363B
+1.11%+0.07%+28.19%+58.61% 301B
+0.24%-0.80%+3.05%+35.93% 286B
+0.64%+2.47%+40.26%+76.85% 253B
+0.47%+1.86%+38.32%+127.80% 211B
Average +0.61%+0.32%+36.73%+84.36% 428B
Weighted average by Cap. +0.96%+0.21%+38.86%+97.17%

Financials

2027 *2028 *
Net sales 25.51B 271M 245M 227M 205M 387M 398M 2.72B 1.08B 13.64B 1.02B 997M 43.41B 30.28B 322M 291M 269M 243M 459M 473M 3.23B 1.28B 16.19B 1.21B 1.18B 51.53B
Net income 7.33B 77.98M 70.52M 65.09M 58.92M 111M 115M 781M 310M 3.92B 293M 286M 12.47B 8.44B 89.82M 81.22M 74.98M 67.86M 128M 132M 900M 358M 4.51B 337M 330M 14.37B
Net Debt -9.44B -100M -90.85M -83.86M -75.9M -143M -148M -1.01B -400M -5.05B -377M -369M -16.07B -8.74B -92.94M -84.05M -77.58M -70.22M -133M -136M -931M -370M -4.67B -349M -341M -14.87B
Projected Income Statement - Annual - Anthem Biosciences Limited
Logo Anthem Biosciences Limited
Anthem Biosciences Limited is an India-based contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. The Company’s segments include CRDMO and Speciality Ingredients. The Company helps new and established biotech’s and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and others. In addition to product research and development, it helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, antibody drug conjugates, research and development and manufacture of highly potent compounds, flow chemistry-based production and large-scale commercial product manufacture. Its CRDMO Services include Large Molecules, Small Molecules, HPAPI, Peptides, Lipids, ADCs and Oligonucleotides.
Employees
2,282
Date Price Change Volume
26-11-12 ₹938.45 -1.99% 355,147
26-11-11 ₹957.50 -0.07% 453,923
26-11-09 ₹958.15 +1.68% 1,725,432
26-11-08 ₹942.35 +2.93% 241,366
26-11-06 ₹915.55 +0.22% 502,815
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Anthem Biosciences Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
938.45INR
Average target price
974.25INR
Spread / Average Target
+3.81%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Anthem Biosciences Limited
  1. Stock Market
  2. Stocks
  3. ANTHEM Stock